HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Health And Wellness Industry News Roundup: Week Of Aug. 8

This article was originally published in The Rose Sheet

Executive Summary

MusclePharm trims loss; Mannatech net sales up 4.5%; Herbalife sells in three more China provinces; and more news in brief.

You may also be interested in...



Omega Protein, Herbalife, MET-Rx: Health And Wellness Industry News

Omega Protein has new home at Canadian aquaculture firm; Herbalife on target with buy-back tender volume, price; and MET-Rx scores Bellinger for promotions.

Health & Wellness Industry Roundup: July 11-15

Compromise GMO legislation passes House; private equity looks for health, wellness investments, including China; and more news in brief.

Industry Roundup: Children's Rhinocort, MusclePharm Restructuring

Senators stir bulk caffeine criticism; AHPA updates membership process; Weiss heads Nutrition 21; and more news in brief.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS108503

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel